Doctorglasses Chain Co Ltd
Doctorglasses Chain Co Ltd operates as a specialty retailer in the eyewear industry, offering a range of prescription and non-prescription glasses, contact lenses, and related services to consumers.
Business. Doctorglasses Chain Co Ltd (300622.SZ) is a miscellaneous specialty retailer listed on the Shenzhen Stock Exchange. The company operates within the Consumer Cyclicals sector, focusing on product sales. Specific details regarding its operating segments and geographic mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Doctorglasses Chain Co Ltd (300622.SZ) is a miscellaneous specialty retailer listed on the Shenzhen Stock Exchange. The company operates within the Consumer Cyclicals sector, focusing on product sales. Specific details regarding its operating segments and geographic mix are not available.
The company maintains a relatively strong liquidity position, with a current ratio of 2.88, indicating that it has sufficient current assets to cover its current liabilities more than two and a half times over. However, the liquidity risk is rated as medium, and the company has a negative net cash position after subtracting total debt, which could pose a challenge in the short term. The debt-to-equity ratio of 0.2 suggests a conservative capital structure, with a relatively low proportion of debt compared to equity.
In terms of profitability, the company's return on equity (ROE) of 16.36% and return on assets (ROA) of 10.95% are both above the industry median for specialty retailers, indicating strong returns relative to its equity and asset base. The operating margin, calculated as operating income of 193.46 million CNY on revenue of 1.36 billion CNY, is 14.22%, which is also above the industry median. This suggests that the company is effectively managing its operating costs and generating solid returns from its core operations.
The company's geographic and segment exposure is not explicitly detailed in the available data, but as a specialty retailer in the eyewear industry, it is likely concentrated in domestic markets. The lack of detailed segment reporting limits the ability to assess the diversification of its revenue streams. However, the company's revenue of 1.36 billion CNY in the latest period suggests a significant presence in the market.
Looking ahead, the company is expected to maintain a stable growth trajectory, with no specific numeric deltas provided for the current or next fiscal year. The company's free cash flow of 234.58 million CNY and operating cash flow of 296.96 million CNY indicate strong cash generation capabilities, which should support continued operations and potential reinvestment. The capital expenditure of -20.67 million CNY suggests that the company is not currently investing heavily in new assets, which may indicate a focus on maintaining existing operations rather than expansion.
The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the available data. The risk assessment indicates a low probability of near-term dilution, and no expected timeframe for dilution pressure. The company's conservative capital structure and strong cash flow generation reduce the likelihood of needing to issue additional shares in the near term. However, the negative net cash position after subtracting total debt is a key flag that should be monitored.
Recent events and filings do not provide specific details on the company's strategic initiatives or major developments. The company's financial performance and risk profile suggest a stable and well-managed business, but the lack of detailed segment and geographic reporting limits the ability to fully assess its exposure to different markets and product lines. The company's strong cash flow and profitability metrics indicate a solid financial foundation, but continued monitoring of its liquidity position and capital structure is advisable.
- The company has a strong return on equity (16.36%) and return on assets (10.95%), indicating effective use of capital and assets.
- The company maintains a conservative capital structure with a debt-to-equity ratio of 0.2, suggesting a low reliance on debt financing.
- The company's liquidity position is strong, with a current ratio of 2.88, but it has a negative net cash position after subtracting total debt.
- The company's free cash flow of 234.58 million CNY and operating cash flow of 296.96 million CNY indicate strong cash generation capabilities.
- The company has a low dilution potential, with no significant dilution sources identified in the available data.
- The company's risk profile is characterized by a low probability of near-term dilution and a medium liquidity risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Doctorglasses Chain Co Ltd Market data — financials · 2026-05-26
- Doctorglasses Chain Co Ltd Market data — analyst estimates · 2026-05-26